| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ZELTIQ AESTHETICS INC | 445,686 | 14,275,000 | 0.40% | ||
| 52 | BARD C R INC | 75,570 | 14,079,000 | 0.40% | ||
| 53 | TEXTRON INC | 357,388 | 13,452,000 | 0.38% | ||
| 54 | HORTONWORKS INC | 589,489 | 12,904,000 | 0.36% | ||
| 55 | OREXIGEN THERAPEUTICS INC | 17,458,000 | 12,101,000 | 0.34% | PRN | |
| 56 | ADAPTIMMUNE THERAPEUTICS PLC | 1,002,953 | 12,005,000 | 0.34% | ||
| 57 | DBV TECHNOLOGIES S A | 273,965 | 9,750,000 | 0.27% | ||
| 58 | CLOVIS ONCOLOGY INC | 4,805,000 | 8,045,000 | 0.23% | PRN | |
| 59 | COHERUS BIOSCIENCES INC COM | 295,579 | 5,923,000 | 0.17% | ||
| 60 | FOAMIX PHARMACEUTICALS LTD | 506,920 | 3,716,000 | 0.10% | ||
| 61 | JUNO THERAPEUTICS INC COM | 73,631 | 2,996,000 | 0.08% | ||
| 62 | ALLERGAN PLC | 314,700 | 2,518,000 | 0.07% | Call | |
| 63 | REGENXBIO INC COM | 107,305 | 2,364,000 | 0.07% | ||
| 64 | MERCK & CO INC | 1,301,300 | 1,750,000 | 0.05% | Put | |
| 65 | KYTHERA BIOPHARMACEUTICALS I | 20,589 | 1,544,000 | 0.04% | ||
| 66 | PTC THERAPEUTICS INC | 428,200 | 1,306,000 | 0.04% | Call | |
| 67 | MAXLINEAR INC COM | 81,398 | 1,013,000 | 0.03% | ||
| 68 | TEVA PHARMACEUTICAL INDS LTD | 2,713,000 | 1,009,000 | 0.03% | Call | |
| 69 | BRISTOL MYERS SQUIBB CO | 2,537,100 | 419,000 | 0.01% | Call | |
| 70 | KERYX BIOPHARMACEUTICALS INCORPORATED | 97,687 | 344,000 | 0.01% | ||
| 71 | Teladoc, Inc. | 13,670 | 305,000 | 0.01% | ||
| 72 | PFIZER INC | 2,207,400 | 265,000 | 0.01% | Call | |
| 73 | ROCKWELL AUTOMATION INC | 388,600 | 87,000 | 0.00% | Call | |
| 74 | MCKESSON CORP | 343,100 | 26,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-066040, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
